Craig Adam R 4
4 · CTI BIOPHARMA CORP · Filed Mar 16, 2023
Insider Transaction Report
Form 4
Craig Adam R
DirectorSee Remarks
Transactions
- Award
Stock Option (right to buy)
2023-03-14+900,000→ 900,000 totalExercise: $4.55Exp: 2033-03-14→ Common Stock (900,000 underlying)
Footnotes (1)
- [F1]The stock option will vest in six equal semi-annual installments over a three-year period, subject to continued employment with the Company through the applicable vesting dates.